Healthy term infants
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Healthy and full-term infants (gestational age > 37 and < 42 weeks); 2. Birth weight within the normal range for sex and gestational age (10th to 90th percentiles according to locally applicable growth charts); 3. 60 days of age or older; 4. Body weight appropriate for the age of 8 weeks and sex (10th to 90th percentiles according to locally applicable growth charts); 5. Written informed consent of both parent(s)/legal guardian(s).
Exclusion criteria
Exclusion criteria: 1. Infants with known congenital diseases or malfunctions e.g. gastrointestinal malformations, haemophilia; 2. Infants having received medical treatment with antibiotics and/or pain medication like paracetamol which may be included in cough syrup or other mixtures) within 4 days before examination; 3. Infants with abnormal growth (too slow or too fast weight gain) within the 10th to 90th percentiles of locally applicable weight-for-age charts for either boys or girls; 4. Infants needing a special diet other than standard cow's milk-based infant milk formula; 5. Infants having a mother suffering from known hepatitis B, HIV, high blood-pressure, hyperlipidaemia or diabetes; 6. Infants having an overweight (BMI > 27) mother prior to her first pregnancy; 7. Infants with any historical participation in any other study involving investigational or marketed products; 8. Investigator's uncertainty about the willingness or ability of the parent(s)/legal guardian(s) to comply with the protocol requirements and instructions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postprandial total plasma triglyceride levels at baseline and 30, 60, 90, 120, 180 or 240 minutes after baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| Differences in total plasma triglyceride levels between 2 feeding regimen (formula feeding vs. breastfeeding), measured at baseline and 30, 60, 90, 120, 180 and 240 minutes after baseline. | — |
Contacts
Nutricia Research BV Uppsalalaan 12